CHRISTEN MCCABE: Open Payments
NPI 1659983948 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,264 in 66 payments from 19 companies in 2025. Trend: 2023 $904 · 2024 $5,406 · 2025 $4,264
Food & beverage: $1,815Consulting: $1,329Travel & lodging: $1,121
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 15 | $2,657 |
| United Therapeutics Corporation | 3 | $303 |
| AstraZeneca Pharmaceuticals LP | 5 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Merck Sharp & Dohme LLC | 6 | $164 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| GENZYME CORPORATION | 3 | $81 |
| Viatris Specialty LLC | 3 | $54 |
Products named: UPTRAVI, Adempas, TEZSPIRE, DUPIXENT, WINREVAIR, OPSUMIT, NUCALA, OFEV.
Industry payments across GA — which companies pay providers there.
